Sentence examples for the pathway at which from inspiring English sources

Order-of-addition experiments are commonly used to pinpoint a step along the pathway at which an antibiotic acts.

Having obtained clear evidence that autoantibodies recognizing SRP54 could interfere with the SRP-dependent targeting process, we investigated the stage of the pathway at which targeting was inhibited.

Knowledge of the mechanistic details of apoptotic induction now provides us with steps in the pathway at which a pharmacologic agent could potentially act to afford inhibition of hair cell death [ 18– 23].

Assuming the trait maps linearly onto flux, then the relationship between fitness and flux is (4) where w G (F) is the fitness of a genotype with relative flux F through the pathway, σ is a measure of the strength of stabilizing selection, with large σ indicting weak selection, and is the optimal flux through the pathway, at which relative fitness is maximal (equal to 1).

It made no sense for its remit to stop at the point on the care pathway at which responsibility for the individual passed from the NHS to social care.

The DFCC 1 is generated as a transient intermediate near the hypothetical branching point of the PaO/phyllobilin pathway at which the type-II phyllobilins diverge from the first formed 1-formyl-19-oxobilin-type Chl catabolites (or type-I phyllobilins).

To contribute to this research and to understand further the point in the care pathway at which inequalities arise, we undertook a national study to examine the extent to which referral for defined symptoms from primary care varied according to patients' age, sex, and socioeconomic circumstances.

We next attempted to delimit the position within the EGFR/ERK1/2 pathway at which a stimulatory signal was generated by dasatinib.

This condensation reaction represents a branch point in the phenylpropanoid pathway, at which CHS channels 4-coumaroyl-CoA molecules towards flavonoid synthesis and STS towards stilbene synthesis.

Application of GSK-5 (500 n m) caused an increase in EPSP amplitude in the control pathway (that had not undergone LTP induction), but importantly no potentiation was observed in the test pathway at which LTP had been induced (Fig. 6 D; GSK-5 potentiation: control pathway 142.2 ± 18.9% vs. test pathway 70.8 ± 10.4%, n = 8, P = 0.0012).

Further studies are required to map the exact point(s) on the IFN induction pathway at which EAV nsp1 acts.